• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    0.76 Up 0.01(1.43%) 4:00PM EDT
    Add to Portfolio
    Prev Close:0.75
    Open:0.81
    Bid:0.74 x 6600
    Ask:0.75 x 6800
    1y Target Est:9.00
    Beta:2.66
    Next Earnings Date:30-Mar-15RXII Earnings announcement
    Day's Range:0.72 - 0.87
    52wk Range:0.72 - 4.73
    Volume:2,141,104
    Avg Vol (3m):520,111
    Market Cap:16.06M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIUp 1.43%16.06M
    ALNYUp 4.44%8.72B
    MRNAUp 3.41%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):184.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.80
    Quarterly EPS Est (Dec-14) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback